Managing Chronic Spinal Pain With Exercise and Neuromodulation
UCV/PSPS
Patient-centered Management of Chronic Spinal Pain by Addressing the Peripheral and Central Component With Exercise and Non-invasive Neuromodulation: A Randomized Control Trial (RCT)
1 other identifier
interventional
42
1 country
1
Brief Summary
Chronic spinal pain is a multifaceted condition frequently characterized by an absence of discernible structural causes, manifesting in symptoms such as significant disability and diminished quality of life. Persistent Spinal Pain Syndrome Type 2 (PSPS-T2) represents a common variant, implicating both peripheral and central nervous system mechanisms. This study investigates the synergistic effects of transcranial direct current stimulation (tDCS) in conjunction with motor control exercises on PSPS-T2 patients who have not responded to conventional treatments. A randomized controlled trial (RCT) will be conducted to compare an experimental group (tDCS + exercise) with a control group (exercise only), with the objective of enhancing functionality, alleviating pain levels, and improving psychological well-being. The findings may contribute to the development of more effective, patient-centered treatment strategies.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Oct 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 5, 2025
CompletedFirst Posted
Study publicly available on registry
May 13, 2025
CompletedStudy Start
First participant enrolled
October 27, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
January 1, 2027
December 8, 2025
April 1, 2025
10 months
May 5, 2025
December 1, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The Oswestry Disability Index (ODI)
The Oswestry Disability Index (ODI) is the most widely used and validated assessment tool for low back pain. It is a self-administered questionnaire divided into ten sections designed to evaluate limitations in activities of daily living. Each section is scored on a scale from 0 to 5, with 5 indicating the highest level of disability. The total index score is calculated by dividing the sum of the section scores by the maximum possible score and multiplying by 100, yielding a percentage. The ODI has been validated in Spanish, demonstrating high sensitivity and specificity for functional assessment.
Pre-treatment, 1-month follow-up, 3-month follow-up, 6-month follow-up
Secondary Outcomes (7)
Tampa Scale 11 (TSK-11)
Pre-treatment, 1-month follow-up, 3-month follow-up, 6-month follow-up
Catastrophizing
Pre-treatment, 1-month follow-up, 3-month follow-up, 6-month follow-up
SF-12
Pre-treatment, 1-month follow-up, 3-month follow-up, 6-month follow-up
Visual Analogue Scale (VAS)
Pre-treatment, 1-month follow-up, 3-month follow-up, 6-month follow-up
DN4 Questionnaire
Pre-treatment, 1-month follow-up, 3-month follow-up, 6-month follow-up
- +2 more secondary outcomes
Study Arms (2)
Exercise + TDCS
EXPERIMENTALThe transcranial direct current stimulation (tDCS) group will undergo 20 minutes of continuous stimulation at an intensity of 1.5 mA over the left dorsolateral prefrontal cortex (DLPFC) during each session. Two saline-soaked sponge electrodes, each measuring 35 cm², will be utilized. In accordance with the international 10-20 EEG electrode placement system, the anodal electrode will be positioned over F3 to specifically target the left DLPFC. The reference electrode will be placed over the left eye to ensure that the current traverses the prefrontal area. A 30-second ramp-up period will be implemented at the commencement of the tDCS stimulation, followed by a 30-second ramp-down period at its conclusion.
Exercise + ShamTDCS
PLACEBO COMPARATORThe device will be configured to produce an upward gradient for 30 seconds, identical to that used in the experimental group, followed by a downward gradient for another 30 seconds. Consequently, the control group will feel a similar tingling on their scalp as the experimental group. This stimulation will occur for a total of 60 seconds, which is insufficient to induce changes in cortical excitability. Studies have demonstrated that this approach effectively ensures patient blinding .
Interventions
Structured treatment sessions, each lasting 30 minutes, will be organized into distinct blocks. In the initial phases, participants will engage in exercises emphasizing core stabilization and general strength training, with a particular focus on forced expiration as a technique to ensure the proper activation of the transversus abdominis muscle. This methodology aims to mitigate adverse effects associated with increased intra-abdominal pressure. To optimize the activation of the transversus abdominis, patients will be instructed to perform a forced expiration while concurrently drawing the navel inward and upward toward the spine, maintaining the lumbar spine in a neutral position. During the initial exercises, ultrasound imaging of the transversus abdominis will be employed as visual feedback, enabling patients to observe muscle thickening during forced expiration. This visual feedback enhances the accuracy of muscle activation and exercise technique. Exercises will be progressively s
The transcranial direct current stimulation (tDCS) protocol will involve the application of a continuous current for 30 minutes, with an intensity ranging from 1 to 1.5 mA, targeting the left dorsolateral prefrontal cortex (DLPFC) during each session. Two saline-soaked sponge electrodes, each measuring 35 cm², will be employed to ensure adequate skin contact. In accordance with the international 10-20 EEG electrode placement system, the anodal electrode will be positioned at the F3 location, specifically targeting the left DLPFC. The reference electrode will be placed above the left eye to facilitate efficient current flow through the prefrontal region of the brain. To enhance both safety and efficacy, a 30-second ramp-up and ramp-down period will be incorporated at the commencement and conclusion of the stimulation session. This methodology is intended to minimize potential adverse effects and ensure an optimal stimulation experience for participants.
The device will be configured to produce an upward gradient for 30 seconds, identical to that used in the experimental group, followed by a downward gradient for another 30 seconds. Consequently, the control group will feel a similar tingling on their scalp as the experimental group. This stimulation will occur for a total of 60 seconds, which is insufficient to induce changes in cortical excitability. Studies have demonstrated that this approach effectively ensures patient blinding.
Eligibility Criteria
You may qualify if:
- Have a diagnostic of PSPS-T2
- Neuropathic pain (DNA4 ≥ 4)
- Patients older than 18 years
- ≥ 6 months with pain
- VAS score ≥ 7
You may not qualify if:
- Previous or programmed surgeries in abdominal area
- Pregnant or lactating
- Severe fractures or pathologies
- Spine structural deformity
- Neurologic or psychiatric issues
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Catholic Univerity of Valencia
Valencia, Valencia, 46001, Spain
Related Publications (3)
Sebaaly A, Lahoud MJ, Rizkallah M, Kreichati G, Kharrat K. Etiology, Evaluation, and Treatment of Failed Back Surgery Syndrome. Asian Spine J. 2018 Jun;12(3):574-585. doi: 10.4184/asj.2018.12.3.574. Epub 2018 Jun 4.
PMID: 29879788BACKGROUNDBursali C, Ozkan FU, Kaysin MY, Dortcan N, Aktas I, Kulcu DG. Effectiveness of Repetitive Transcranial Magnetic Stimulation in Patients With Failed Back Surgery Syndrome: A Double-Blind Randomized Placebo-Controlled Study. Pain Physician. 2021 Jan;24(1):E23-E30.
PMID: 33400434BACKGROUNDHuertas-Ramirez B, Jaenada-Carrilero E, Belda-Antoli M, Leal-Garcia J, Alonso-Martin M, Mahiques-Sanchis A, Benlloch-Garcia A, Falaguera-Vera F, Vicente-Mampel J. Patient-Centered Chronic Spinal Pain Management Using Exercise and Neuromodulation: Study Protocol for a Randomized Controlled Trial. Healthcare (Basel). 2025 Nov 24;13(23):3032. doi: 10.3390/healthcare13233032.
PMID: 41373250DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Borja Huertas Ramirez Juan Vicente Mampel, Phd Studente
CONTACT
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- The guidelines and treatment protocols will be overseen by the principal investigator and a team of specialist physiotherapists, each with over 10 years of experience in the management of neuromodulation and exercise therapy for chronic lumbar pain. Stratified randomization will be implemented to ensure that the compared groups are balanced with respect to the level of neuropathic pain. Prior to the randomization process, the baseline level of neuropathic pain shall be identified. Two strata of participants will be established within their own group. Subgroup 1 will include those participants who are on the DN4 scale of a value of 4,5,6 or 7. In subgroup 2 will be patients who are on the DN4 scale of a value of 8,9 or 10.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 5, 2025
First Posted
May 13, 2025
Study Start
October 27, 2025
Primary Completion (Estimated)
September 1, 2026
Study Completion (Estimated)
January 1, 2027
Last Updated
December 8, 2025
Record last verified: 2025-04
Data Sharing
- IPD Sharing
- Will not share